Keros Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Keros Therapeutics, Inc. on November 26, 2024. The filing serves as a Regulation FD disclosure regarding upcoming investor relations activities.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or operational metrics.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces scheduled conference presentations.
Guidance, Outlook, and Management Commentary
Management has announced that Jasbir Seehra, Chair and Chief Executive Officer, will participate in the following events:
- Piper Sandler 36th Annual Healthcare Conference: Tuesday, December 3, 2024, at 10:30 a.m. Eastern time.
- 7th Annual Evercore HealthConx Conference: Wednesday, December 4, 2024, at 3:00 p.m. Eastern time.
The press release detailing these events is included as Exhibit 99.1. The filing explicitly states that the information is not "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the upcoming fireside chats at the Piper Sandler and Evercore conferences.
- Review the full text of the press release (Exhibit 99.1) for any additional commentary not summarized in the 8-K.
- Confirm that no financial data or material contracts were disclosed in this specific filing.